×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Break Out Sessions 2A: Complex Innovative Design Trials
Session Chair(s)
Daniel Millar, MBA
Senior Director, Strategic Business Transformation
Johnson & Johnson, United States
Complex Innovative Design Trials
Speaker(s)
Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project
Cecile Spiertz, MSc
Netherlands
Protocol Development for Master Protocol Studies – Balancing Structure with Function
Jonathan Mackinnon, PhD
Parexel, Spain
Associate Director, Medical Writing Services
Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers
Christine Fletcher, MSc
GlaxoSmithKline, United Kingdom
VP/Head, Speciality and Primary Care Statistics
Panel discussion with Q&A
Olga Kholmanskikh Van Criekingen, MD, PhD
Federal Agency for Medicines and Health Products, Belgium
Clinical assessor
Have an account?